` 6929 (OrbusNeich Medical Group Holdings Ltd) vs Hang Seng (Hong Kong) Comparison - Alpha Spread

6929
vs
Hang Seng (Hong Kong)

Over the past 12 months, has underperformed Hang Seng (Hong Kong), delivering a return of -40% compared to the Hang Seng (Hong Kong)'s 18% growth.

Stocks Performance
6929 vs Hang Seng (Hong Kong)

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
6929 vs Hang Seng (Hong Kong)

Loading
6929
Hang Seng (Hong Kong)
Difference

Performance By Year
6929 vs Hang Seng (Hong Kong)

Loading
6929
Hang Seng (Hong Kong)
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
OrbusNeich Medical Group Holdings Ltd vs Peers

Hang Seng (Hong Kong)
6929
7741
ALC
COLO B
ALGN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

OrbusNeich Medical Group Holdings Ltd
Glance View

Market Cap
3.1B HKD
Industry
Health Care

OrbusNeich Medical Group Holdings Ltd. operates as an investment holding company. The company employs 880 full-time employees The company went IPO on 2022-12-23. The firm is engaged in the design, development, manufacture, distribution and sale of interventional medical devices for the treatment of coronary heart disease and peripheral vascular diseases. The firm's main products include percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) balloons. In addition, the Company's products also include semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, coronary stents for implantation, non-compliant balloons for post-dilatation and specialty catheters. The firm mainly conducts its businesses in domestic and overseas markets.

Intrinsic Value
3.71 HKD
Fairly Valued
Intrinsic Value
Price
O
Back to Top